Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Atazanavir (BMS-232632) in HIV-1 Infection
NCT00002240Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 1999
- Primary completion
- Dec 2001
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of atazanavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Bristol Myers Squibb. Started Mar 1999; status: completed.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00002240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002240.